These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10397504)

  • 1. Synthesis and evaluation of 1-position-modified inositol 1,4,5-trisphosphate analogs.
    Inoue T; Kikuchi K; Hirose K; Iino M; Nagano T
    Bioorg Med Chem Lett; 1999 Jun; 9(12):1697-702. PubMed ID: 10397504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrophobic modifications at 1-phosphate of inositol 1,4,5-trisphosphate analogues enhance receptor binding.
    Nakanishi W; Kikuchi K; Inoue T; Hirose K; Iino M; Nagano T
    Bioorg Med Chem Lett; 2002 Mar; 12(6):911-3. PubMed ID: 11958992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, acid-base behavior, and binding properties of 6-modified myo-inositol 1,4,5-tris(phosphate)s.
    Ballereau S; Guédat P; Poirier SN; Guillemette G; Spiess B; Schlewer G
    J Med Chem; 1999 Nov; 42(23):4824-35. PubMed ID: 10579845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of analogues of myo-inositol 1,4,5-trisphosphate that contain sulfonamide, sulfate, methylphosphonate, and carboxymethyl groups.
    Westerduin P; Willems HA; van Boeckel CA
    Carbohydr Res; 1992 Oct; 234():131-40. PubMed ID: 1334798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of (+/-)-2-O-[4'-(N-9''-purinyl)butyl] myo-inositol 1,4,5-tris(phosphate), a potent full agonist at the D-myo-inositol 1,4,5-tris(phosphate) receptor.
    Moris MA; Caron AZ; Guillemette G; Rognan D; Schmitt M; Schlewer G
    J Med Chem; 2005 Feb; 48(4):1251-5. PubMed ID: 15715492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereospecific recognition of inositol 1,4,5-trisphosphate analogs by the phosphatase, kinase, and binding proteins.
    Hirata M; Yanaga F; Koga T; Ogasawara T; Watanabe Y; Ozaki S
    J Biol Chem; 1990 May; 265(15):8404-7. PubMed ID: 2160455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and binding properties of cyclopentane analogues of myo-inositol 1,4,5-tris(phosphate).
    Moris MA; Caron AZ; Guillemette G; Schlewer G
    Bioorg Med Chem; 2004 Aug; 12(15):3995-4001. PubMed ID: 15246076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic inositol trisphosphate analogs and their effects on phosphatase, kinase, and the release of Ca2+.
    Hirata M; Watanabe Y; Ishimatsu T; Ikebe T; Kimura Y; Yamaguchi K; Ozaki S; Koga T
    J Biol Chem; 1989 Dec; 264(34):20303-8. PubMed ID: 2555352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of types-1 and -3 inositol trisphosphate receptors by cytosolic Ca2+.
    Cardy TJ; Traynor D; Taylor CW
    Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):785-93. PubMed ID: 9396721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimers of D-myo-inositol 1,4,5-trisphosphate: design, synthesis, and interaction with Ins(1,4,5)P3 receptors.
    Riley AM; Laude AJ; Taylor CW; Potter BV
    Bioconjug Chem; 2004; 15(2):278-89. PubMed ID: 15025523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biology of inositol polyphosphate analogues.
    Potter BV; Nahorski SR
    Biochem Soc Trans; 1992 May; 20(2):434-42. PubMed ID: 1327920
    [No Abstract]   [Full Text] [Related]  

  • 12. Defining the minimal structural requirements for partial agonism at the type I myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA; Fauq A; Kozikowski AP; Nahorski SR
    FEBS Lett; 1997 Feb; 402(2-3):241-5. PubMed ID: 9037203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inositol 1,4,5-trisphosphate receptors: labeling the inositol 1,4,5-trisphosphate binding site with photoaffinity ligands.
    Mourey RJ; Estevez VA; Marecek JF; Barrow RK; Prestwich GD; Snyder SH
    Biochemistry; 1993 Feb; 32(7):1719-26. PubMed ID: 8382518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of the ligand binding site of the inositol 1,4,5-trisphosphate receptor.
    Yoshikawa F; Morita M; Monkawa T; Michikawa T; Furuichi T; Mikoshiba K
    J Biol Chem; 1996 Jul; 271(30):18277-84. PubMed ID: 8663526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inositol 1,4,5-trisphosphate (InsP3) receptor.
    Bezprozvanny I; Ehrlich BE
    J Membr Biol; 1995 Jun; 145(3):205-16. PubMed ID: 7563022
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological characterization of inositol-1,4,5,-trisphosphate binding to membranes from retina and retinal cultures.
    López-Colomé AM; Lee I
    J Neurosci Res; 1996 Apr; 44(2):149-56. PubMed ID: 8723223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, calcium mobilizing, and physicochemical properties of D-chiro-inositol 1,3,4,6-tetrakisphosphate, a novel and potent ligand at the D-myo-inositol 1,4,5-trisphosphate receptor.
    Liu C; Davis RJ; Nahorski SR; Ballereau S; Spiess B; Potter BV
    J Med Chem; 1999 Jun; 42(11):1991-8. PubMed ID: 10354407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of inositol 1,4,5-trisphosphate binding to the various inositol 1,4,5-trisphosphate receptor isoforms by thimerosal and cyclic ADP-ribose.
    Vanlingen S; Sipma H; De Smet P; Callewaert G; Missiaen L; De Smedt H; Parys JB
    Biochem Pharmacol; 2001 Apr; 61(7):803-9. PubMed ID: 11274965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IP3 receptor-ligand. 2: Synthesis and molecular mechanics calculation of adenophostin A.
    Hotoda H; Takahashi M; Tanzawa K; Takahashi S; Miyamoto S; Kaneko M
    Nucleic Acids Symp Ser; 1995; (34):163-4. PubMed ID: 8841603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium signalling: how do IP3 receptors work?
    Dawson AP
    Curr Biol; 1997 Sep; 7(9):R544-7. PubMed ID: 9285705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.